Sign In
Free Newsletter
Cellares cuts the ribbon on Bridgewater smart factory facility
Located in a building formerly occupied by Pfizer, the company's flagship cell therapy manufacturing site is expected to create 350 local jobs.
Dr. Reddy’s signs 53K-square-foot lease in Plainsboro (updated)
Highlighting the draw of Mercer and Middlesex counties – and updated spaces – Cushman & Wakefield also arranged a renewal for 63,000 square feet at office property Princeton Point.
NJ offers assistance package for entrepreneurs hit by SVB collapse
Approximately $35 million in short-term support will be available to Garden State companies impacted by the fallout.
Insmed’s Bridgewater HQ trades for $39M
EQT Exeter acquired the 117-square-foot property in 2017, subsequently renovating, leasing and ultimately selling the asset.
Princeton life science facility changes hands in sale arranged by CushWake
The property is fully leased to a provider of chemistry and biopharmaceutical services that more than doubled its footprint at the location in December 2021 to fully occupy the property.
Low industrial vacancies, lack of lab space leads to rent increases
Two recent reports from CBRE highlight the impact that demand is having on tenants' costs as warehouse leases expire and life sciences companies look to expand.
Transformative design
Copenhagen, Denmark-based biotechnology company Genmab chose to plant roots in Princeton because it saw the former home of Bristol-Myers Squibb as an ideal fit. With the help of Morristown architecture firm Gensler, a $20 million renovation and office-to-lab conversion at the property repositioned the lab as the center of the company's work culture across its 135,000-square-foot footprint.
CBRE: Office-to-lab conversions sweep across the Northeast
Research indicates markets in the area demonstrate that a variety of commercial property types are suitable for the switch and can offer lab space in unique buildings and locations where none previously existed.
Life-science lab space remains strong in NJ
One of the most sought-after states for both venture capital investors and premier pharmaceutical companies, New Jersey ranked among the industry top clusters in the U.S. in Q1 2021, according to a new report from CBRE.
